May 13, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014 - Antagonist - Document - PDFSEARCH.IO

First Page	Meta Content
	May 13, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014 Add to Reading List Document Date: 2014-05-13 01:55:31 Open Document File Size: 221,36 KB Share Result on Facebook

UPDATE

May 13, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014Add to Reading List